BGI Genomics 2023 Global State of Thalassemia Awareness Report (IMAGE)
Caption
Due to its hereditary nature, carrier screening using genetic technology is an essential tool in preventing the transmission of thalassemia. High-throughput sequencing (HTS) technology, such as BGI Genomics’ VISTA Carrier Screening, offers an efficient and accurate way to detect thalassemia carriers before pregnancy. By identifying carriers, families can make informed decisions and reduce the risk of having a child with thalassemia major, helping to break the inherited chain of the disease and prevent unnecessary suffering.
Credit
BGI Genomics
Usage Restrictions
None
License
Original content